What Causes Kidney Stones? In our latest podcast, a team of health pros debunks myths, shares facts, and offers real-world strategies to stop stones before they start. 🎙️ From diet to hydration to meds—we’ve got it covered. 🔗 Listen now!

The Prevalence and Characteristics of #IgA Antibodies to β2-spectrin and #CBX3 in IgA Nephropathy #VisualAbstract by @edgarvlermamd.bsky.social www.kireports.org/ar...

The origin story of #sockittokidneydisease from David Rush #worldkidneydisease podcasts.apple.com/us/podcast/t...

Does autoimmunity underlie minimal change disease? Tobias B. Huber, Nicola M. Tomas & team report a direct pathogenic role of anti-nephrin autoantibodies in the development of podocytopathy with a minimal change disease phenotype: buff.ly/xTRvnoZ

Microvascular Inflammation in TX Biopsies - As compared with pts without rejection, the hazard ratio for graft loss was 2.1 among patients with microvascular inflammation without evidence of an antibody-mediated response & 2.7 among patients with ABMR www.nejm.org/doi/full/10.... @nejm.org #nephsky

🔴Los editores de @ajkd.bsky.social seleccionan el artículo del estudio #GENSEN como investigación relevante para celebrar el #WorldKidneyDay #DíaMundialdelRiñón 👏👏 🔴Se trata de un gran trabajo multicéntrico realizado por SOCIOS S.E.N. ¡GRACIAS! 👇👇 ajkd.org/content/worl...

but also the idea that you could have indirect costs AS A GRANT APPLICATION SECTION. Your institution runs 15% overhead? Cool, the NIH likes you. But: you need 60%? Well you score less on that grant section, suck it. Intriguing ideas that people ignored. (Until now everyone's an expert, that is.)

New in the February 6, 2025, issue of NEJM: Iptacopan in IgA Nephropathy (APPLAUSE-IgAN phase 3 trial) nej.md/3UmrOkh Atrasentan in Patients with IgA Nephropathy (ALIGN phase 3 trial) nej.md/3NzvISW Liraglutide for Children with Obesity (SCALE Kids phase 3a trial) nej.md/3MBP1uc #MedSky

🎉 Thrilled to share our commentary in Kidney International Reports ✅Is it time to expand the use of SGLT2 inhibitors in KTRs? ▶️Read on www.kireports.org/article/S246... @theisn.org @kireports.bsky.social @myadla.bsky.social @hswapnil.medsky.social @brianrifkin.bsky.social

Pretty incredible, very hopeful for a similar story to PLA2r

🔬 Genetic testing is a game-changer in nephrology, but it’s still not routine practice. This paper lays out a clear framework for when and how to use genetic testing in kidney care. 🧵1/4 www.sciencedirect.com/science/arti...

Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome @aspneph @capneph #medsky #nephsky https://buff.ly/4aC7NNn

ASN Publications is on Cloud 9 to announce that we’re now on Bluesky! Follow us @asnpublications.bsky.social for the latest from JASN, CJASN, Kidney360, and Kidney News, and tag us in your publication posts too. @asnkidney.bsky.social @kdjhaveri.bsky.social @rajmehrotra.bsky.social

Non-oliguric acute renal failure secondary to a potentially lethal dose of caffeine with acute intoxication: a case report #nephsky bmcnephrol.biomedcentral.com/articles/10....

Clinicopathologic Characteristics of Crystalglobulin-Induced Nephropathy: A Case Series https://bit.ly/3VyxrMC #VisualAbstract

So very happy with this publication! I hope it will assist trainees in #nephrology and #renalpath in the uses of IF. karger.com/gdz/article/...

New on the #AJKDBlog: Timothy Yau interviews Dr. Anuja Java about Clinical Genetic Testing in Nephrology: Core Curriculum 2024 https://bit.ly/3VtjcZp (FREE)

𝗜𝗦𝗡 𝗠𝗘𝗠𝗕𝗘𝗥𝗦: Join an expert-led course in Kenya on Glomerulonephritis Management – Free registration and travel grants available ow.ly/W96050UnIkn

A big welcome to @nejm.org to #bluesky! #medsky

💇‍♀️Brazilian hair straightening and Oxalate Nephropathy 😱 www.kidney-international.org/article/S008...

I love thi! @anujajava.bsky.social much needed work!

Great original and commentary work!! As often happens, big answers are hidden just in front of our eyes!! #APOL1 #FSGS #RareDisease #NephSky #MedSky

I have just done my first prescription for targeted release budesonide (kinpeygo) last week🙏 Want to know the factors that influence response to this drug? Paper on this topic now out in CKJ 📣 academic.oup.com/ckj/advance-...

Delighted to share our latest paper: "The glomerular circadian clock temporally regulates basement membrane dynamics and the podocyte glucocorticoid response" Expertly led by Rebecca Preston & in collaboration with clock superstar Qing Jun Meng pubmed.ncbi.nlm.nih.gov/39515644/ Key findings 👇👇

The David Koch Jr. Glomerular Kidney Center at Columbia University Irving Medical Center is excited to announce our first Bluesky account! Feel free to follow us and we will follow you back.

🔬EPeP is a free resource w/ interactive cases that make learning fun and easy. Dive into real-life scenarios, get instant feedback + print a certificate when you’re done. It’s all FREE! 🔗 pathology.emory.edu/epep #PathSky #Pathology #PathResidents #MedSky #Path2Path #PathMatch25 #PathMatch2025

Leaves are falling but the sky is blue!

For puzzle lovers and lovers of a puzzling GN!

we got RSS! openrss.org/blog/bluesky...

Don’t forget to sign up for the upcoming Rare Kidney Disease Conference (virtual and in-person). 300 registrations so far!! www.eeds.com/portal_live_...

Welcome to Bluesky [email protected]

Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series bit.ly/4exkQ2W #VisualAbstract

Highlights from the latest issue of AJKD with plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters: - Extreme Heat and Mortality in Dialysis - Chronic Tonsillitis & IgAN Risk in Japan - Kidney Care in Times of Crises bit.ly/48Av7dl

You had me at reduced complement activation Pilot study of SGLT-2 inhibitor empagliflozin shows reduced intrarenal complement activation in patients with diabetes and chronic kidney disease www.kireports.org/article/S246...

Joining today and so happy to see familiar and faces. @washunephrology.bsky.social @anujajava.bsky.social @jzrenlapath.bsky.social @glombandit.bsky.social @poyanmehr.bsky.social @rajgupta-renalpath.bsky.social @renalrhapsody.bsky.social @changucanspare.bsky.social @jeffminerphd.bsky.soc